111 related articles for article (PubMed ID: 14598215)
21. Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells.
Liu L; Xu DM; Cheng YY
J Agric Food Chem; 2008 Feb; 56(3):824-9. PubMed ID: 18197618
[TBL] [Abstract][Full Text] [Related]
22. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
23. Multiple hormonal activities of UV filters and comparison of in vivo and in vitro estrogenic activity of ethyl-4-aminobenzoate in fish.
Kunz PY; Fent K
Aquat Toxicol; 2006 Oct; 79(4):305-24. PubMed ID: 16911836
[TBL] [Abstract][Full Text] [Related]
24. Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities.
Bovee TF; Schoonen WG; Hamers AR; Bento MJ; Peijnenburg AA
Anal Bioanal Chem; 2008 Feb; 390(4):1111-9. PubMed ID: 18188547
[TBL] [Abstract][Full Text] [Related]
25. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
26. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 May; 72(6):547-51. PubMed ID: 16773539
[TBL] [Abstract][Full Text] [Related]
27. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
[TBL] [Abstract][Full Text] [Related]
28. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.
Bovee TF; Helsdingen RJ; Rietjens IM; Keijer J; Hoogenboom RL
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):99-109. PubMed ID: 15276617
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and cell cycle effects of synthetic 8-prenylnaringenin and derivatives in human cells.
Tokalov SV; Henker Y; Schwab P; Metz P; Gutzeit HO
Pharmacology; 2004 May; 71(1):46-56. PubMed ID: 15051922
[TBL] [Abstract][Full Text] [Related]
31. Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line.
Amer DA; Kretzschmar G; Müller N; Stanke N; Lindemann D; Vollmer G
J Steroid Biochem Mol Biol; 2010 Jun; 120(4-5):208-17. PubMed ID: 20433925
[TBL] [Abstract][Full Text] [Related]
32. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
[TBL] [Abstract][Full Text] [Related]
33. Estrogenic activities of isoflavones and flavones and their structure-activity relationships.
Choi SY; Ha TY; Ahn JY; Kim SR; Kang KS; Hwang IK; Kim S
Planta Med; 2008 Jan; 74(1):25-32. PubMed ID: 18095219
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
35. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity.
Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M
Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981
[TBL] [Abstract][Full Text] [Related]
36. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin.
Orallo F; Camiña M; Alvarez E; Basaran H; Lugnier C
Planta Med; 2005 Feb; 71(2):99-107. PubMed ID: 15729616
[TBL] [Abstract][Full Text] [Related]
37. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
38. Phytoestrogens: a review of the present state of research.
Ososki AL; Kennelly EJ
Phytother Res; 2003 Sep; 17(8):845-69. PubMed ID: 13680814
[TBL] [Abstract][Full Text] [Related]
39. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
40. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
Gunawardena K; Campbell LD; Meikle AW
Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
